Indraprastha Medical Corporation Limited
Quick Take
- • Trading at 17.7× trailing earnings (14.9× forward)
- • Strong ROE at 25.4%
- • Low leverage (D/E 0.05)
- • Modest dividend yield of 1.10%
- • Operating margin 16.8% · Net margin 12.3%
- • Profit growth +8.60% YoY · Beta 0.43
Latest quarter · Jun 2026
| ₹ Cr | Jun 2026 | QoQ | YoY |
|---|---|---|---|
| Revenue | 406 | +11.23% | +21.56% |
| Operating Profit | 88 | +29.41% | +29.41% |
| Net Profit | 56 | +33.33% | +36.59% |
| EPS (₹) | 6.09 | +33.85% | +36.24% |
Shareholding Pattern
| Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|
| Promoters | 51.00% | 51.00% | 51.00% | 51.00% | 51.00% | 51.00% | 51.00% | 51.00% |
| FIIs▲0.33 | 2.64% | 2.88% | 2.94% | 2.72% | 2.41% | 2.73% | 2.44% | 2.77% |
| DIIs▼0.29 | 3.20% | 3.19% | 3.56% | 3.56% | 3.51% | 0.83% | 0.88% | 0.59% |
| Government | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public▼0.05 | 43.16% | 42.93% | 42.51% | 42.72% | 43.08% | 45.44% | 45.69% | 45.64% |
| No. of Shareholders | 64,671 | 69,697 | 70,491 | 70,211 | 70,914 | 71,225 | 72,980 | 75,098 |
* 1) Indraprastha Medical Corporation Limited (the Company) is a joint venture between the Government of NCT of Delhi (GNCTD) and Apollo Hospitals Enterprise Limited (AHEL), both being the promoters of the Company. At the time of incorporation of the Company in 1988, Ms. Vineeta Rai, then an officer of the GNCTD, was one of the subscribers to the Memorandum and Articles of Association (MOA & AOA). Accordingly, one equity share was allotted in her name as a subscriber under the Promoter category. The said share is beneficially owned by the GNCTD and continues to be held in physical form in h
| Date | Party | Type | Side | Qty | Price |
|---|---|---|---|---|---|
| 8 Oct 25 | Graviton Research Capital Llp | Bulk deal | BUY | 12,32,834 | ₹587.07 |
| 8 Oct 25 | Graviton Research Capital Llp | Bulk deal | SELL | 12,32,350 | ₹586.98 |
| 7 Oct 25 | Sway Financial Services | Bulk deal | BUY | 4,87,634 | ₹555.26 |
| 7 Oct 25 | Sway Financial Services | Bulk deal | SELL | 9,294 | ₹512.53 |
About the company
From latest AR & concallIndraprastha Medical Corporation Limited provides hospital services in India. The company offers services primarily in the areas of sugar, genomic medicine, elder care, anesthesiology, bariatric and metabolic surgery, bone marrow transplant, dental and cosmetic clinic, dermatology, dietetics and clinical nutrition, vascular and endovascular surgery, endocrinology, ENT, fetal medicine, general and laparoscopic surgery, gynecology and obstetrics, hyperbaric oxygen therapy, IVF, neonatology, nephrology, nuclear medicine, ophthalmology, pediatric sciences, urology, and plastic surgery, as well as pediatric urology and surgery, physiotherapy and rehabilitation, psychiatry and clinical psychology, radiology and radio diagnosis, respiratory, rheumatology, spine surgery, urology and andrology, cardiology, oncology, emergency, gastroenterology, neuroscience, critical care, orthopedics, robotic surgery, and organ transplant, as well as laboratory services, interventional medicine, preventive medicine, and sleep medicine. Indraprastha Medical Corporation Limited was founded in 1983 and is based in New Delhi, India.
